Medical Advisory Board

Farrukh T. Awan, M.D.

Associate Professor of Internal Medicine
Director of Lymphoid Malignancies Program
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, TX

Danielle M. Brander, MD

Division of Hematologic Malignancies & Cellular Therapy
Duke University Health System
Durham, North Carolina

John C. Byrd, MD

The Gordon and Helen Hughes Taylor Professor and Chair
Department of Internal Medicine
University of Cincinnati College of Medicine
Cincinnati, OH

Alexey V. Danilov MD, PhD

Professor, Department of Hematology
Associate Director, Lymphoma Center
City of Hope National Medical Center
Duarte, CA

Matthew S. Davids, MD, MMSc

Associate Director, Center for Chronic Lymphocytic Leukemia
Dana Farber Cancer Institute.
Boston, MA

Ian Flinn, MD, PhD

Director, Lymphoma Research; Principal Investigator
Sarah Cannon Center for Blood Cancer at Tennessee Oncology and TriStar Centennial Medical Center
1100 Dr. Martin L. King Jr. Blvd., Suite 800
Nashville, TN 37203

Richard Furman, MD

Director of the CLL Research Center
Member of the Lymphoma/Myeloma Service
Division of Hematology/Oncology
Weill Cornell Medical College
New York, NY

Thomas E Henry III, MBA, RPh, CPh

President and Senior Consultant, Burlington Consulting Associates
Has served as Chief Pharmacy Officer at two Top-15 Comprehensive Cancer Centers, Moffitt (Tampa, FL) and Roswell Park, (Buffalo, NY)

Brian Hill, MD, PhD

Taussig Cancer Center
Cleveland Clinic

Peter Hillmen, PhD, MB ChB

Professor of Experimental Haematology, University of Leeds
and Honorary Consultant Haematologist, Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom

Kaitlin Kennard, BSN, RN

CLL Program Nurse
Center for Chronic Lymphocytic Leukemia
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, PA

Thomas Kipps, MD, PhD

Professor of Medicine
Division of Hematology-Oncology
Deputy Director of Research
University of California, San Diego Moores Cancer Center
La Jolla, CA

Brian Koffman, MDCM, DCFP, DABFM, MS ED

Retired Family Doctor
Retired Clinical Professor in Family Medicine at the Keck School of Medicine, USC
Chief Medical Officer and Executive Vice President of the CLL Society Inc.
Claremont, CA

Nicole Lamanna, MD

Department of Medicine, Columbia University Medical College
Division of Hematology Oncology
Associate Professor of Clinical Medicine

Susan J. Leclair, Ph.D., CLS (NCA)

Chancellor Professor Emerita
University of Massachusetts
Dartmouth, Massachusetts
Senior Scientist, Forensic DNA Associates, LLC
Dartmouth, Massachusetts

Anthony Mato, MD, MSCE

Director, CLL Program
Memorial Sloan Kettering Cancer Center
New York, NY

Susan M. O’Brien, MD

Associate Director for Clinical Science, Chao Family Comprehensive Cancer Center
Medical Director, Sue & Ralph Stern Center for Cancer Clinical Trials & Research
Professor, Division of Hematology/Oncology, School of Medicine, UC Irvine Health Sciences
Orange, CA

John M. Pagel, MD, PhD

Chief of the Hematologic Malignancy Program and Director of Stem Cell Transplantation
Center for Blood Disorders and Stem Cell Transplantation
Swedish Cancer Institute
Seattle, WA

View Bio

Sameer Parikh, MBBS, MD

Assistant Professor, Hematology
Mayo Clinic
Rocherster, MN

Guilherme Perini, MD

Head of Hematology, Américas Oncologia, Sao Paulo, Brazil
Chief of Lymphoma, Hospital Municipal da Vila Santa Catarina, Sao Paulo, Brazil.
Certificate of Competence in Lymphoma, European School of Oncology/Ulm University

Steven T Rosen, MD

Provost and Chief Scientific Officer
Director, Comprehensive Cancer Center and Beckman Research Institute
City of Hope
Duarte, CA

Lindsey Roeker, MD

Medical Oncology/Hematology Fellow
Memorial Sloan Kettering Cancer Center
New York, NY

John Seymour, MB, PhD

Associate Director of Clinical Research at the Peter MacCallum Centre
Director of the Department of Haematology of the Peter MacCallum Cancer Centre & the Royal Melbourne Hospital
Melbourne, Australia

Alan Skarbnik, MD

Director of the lymphoproliferative disorders program and experimental therapeutics, malignant hematology
Novant Health
Charlotte, NC

Mazyar Shadman MD, MPH

Assistant professor, Department of Medical Oncology, University of Washington
Assistant Member, Clinical research division, Fred Hutch
Attending Physician, Seattle Cancer Care Alliance
Seattle, WA

Sanjay Sharma, MD

Hemotologist/Oncologist
St. Jude Medical Center
Fullerton, CA

Tanya Siddiqi, MD

Director, Chronic Lymphocytic Leukemia Program, Toni Stephenson Lymphoma Center
Associate Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center
Duarte, CA

Kostas Stamatopoulos, MD, PhD

Director of the Institute of Applied Biosciences
CERTH, Centri for Research and Technology
Hellas, Thessaloniki, Greece

Deborah Stephens, DO

Assistant Professor of Hematology and Hematologic Malignancies
The University of Utah Health/The Huntsman Cancer Institute
Salt Lake City, UT

Chris Stewart

Senior Partner
Gallup Inc.
Washington, DC

William G. Wierda, MD, PhD

D.B. Lane Cancer Research Distinguished Professor
Clinical Medical Director – Department of Leukemia
Executive Medical Director
The University of Texas MD Anderson Cancer Center
Houston, TX

Adrian Wiestner, MD, PhD

Senior Researcher
Laboratory of Lymphoid Malignancies
NHLBI (National Heart, Lung, and Blood Institute)
NIH (National Institutes of Health)
Bethesda, MD